COZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.858
EU - Europa 627
AS - Asia 159
AF - Africa 4
Totale 2.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.855
IE - Irlanda 153
SE - Svezia 122
IT - Italia 89
UA - Ucraina 82
HK - Hong Kong 56
DE - Germania 50
FI - Finlandia 37
TR - Turchia 35
CN - Cina 32
GB - Regno Unito 23
CH - Svizzera 20
PL - Polonia 18
VN - Vietnam 18
BE - Belgio 13
JO - Giordania 8
SG - Singapore 7
FR - Francia 6
RO - Romania 6
BG - Bulgaria 5
SC - Seychelles 4
CA - Canada 3
RU - Federazione Russa 3
IN - India 1
JP - Giappone 1
TW - Taiwan 1
Totale 2.648
Salva come PNG Salva come JPEG
Città #
Fairfield 291
Chandler 193
Ashburn 176
Dublin 153
Woodbridge 131
Cambridge 127
Jacksonville 123
Houston 119
Seattle 107
Wilmington 98
Ann Arbor 78
Altamura 41
Princeton 39
Lawrence 36
Boardman 35
Boston 28
Hong Kong 24
Bern 20
San Diego 19
Beijing 18
Dong Ket 18
Warsaw 18
Washington 16
Medford 14
Brussels 13
Izmir 13
Shanghai 13
Buffalo 12
Norwalk 10
Florence 8
New York 8
Milan 7
Timisoara 6
Auburn Hills 5
Los Angeles 5
Sofia 5
Andover 4
Hillsboro 4
Salerno 4
Singapore 4
Verona 4
London 3
Toronto 3
Capri 2
Falls Church 2
Frankfurt Am Main 2
Tappahannock 2
Chicago 1
Hangzhou 1
Lappeenranta 1
Laurel 1
Napoli 1
Philadelphia 1
Pune 1
Rome 1
Saint Petersburg 1
San Mateo 1
Taichung 1
Thiene 1
Tokyo 1
Totale 2.074
Salva come PNG Salva come JPEG
Nome #
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. 125
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 106
NAPOR-3 RNA binding protein is required for apoptosis in hippocampus 104
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 102
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. 93
Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia 89
Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice. 88
Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex 86
Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. 85
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 82
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex 82
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine 80
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. 80
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. 80
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 79
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors 78
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia 77
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage 77
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 76
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex 75
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors 74
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death 73
Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? 69
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 68
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus 68
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 65
Alteration of the subcellular and tissue distribution of ELAV-type proteins during cerebral ischemia in the rat 59
Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. 58
GPR35 is functionally expressed in astrocytes and mediates kynurenic acid-dependent reduction of excitatory synaptic activity at CA3-CA1 synapse. 56
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 52
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 42
Protection with mGlu1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms 41
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 39
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 35
GLT-1 expression and glutamate uptake in rat cerebral cortex are increased by phencyclidine 35
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 35
The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil. 29
Kynurenic acid actions in brain and periphey 27
Totale 2.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019264 0 0 0 0 0 0 0 0 0 52 112 100
2019/2020648 55 42 18 59 69 80 73 86 67 37 50 12
2020/2021352 37 21 25 47 7 33 9 32 29 44 23 45
2021/2022244 10 25 15 11 11 11 15 16 14 11 38 67
2022/2023740 65 120 42 57 67 133 101 39 65 5 17 29
2023/2024226 7 26 47 22 23 53 11 33 3 1 0 0
Totale 2.669